Form 4 · Filed May 27, 2026, 08:16 PM UTC
MAZE/Maze Therapeutics, Inc.
Coloma Jason V — Chief Executive Officer
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| May 26, 2026 | S | sell | 25,582 | $26 | $665,516 | 350,987 |
| May 22, 2026 | S | sell | 4,504 | $26 | $117,104 | 376,569 |
| May 22, 2026 | S | sell | 2,478 | $26 | $64,428 | 28,523 |
Source: SEC EDGAR raw filing ↗ · Accession 0001676170-26-000007